Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Management of Aromatase Inhibitor-Induced Musculoskeletal Pain

Evidence-Based Treatment Recommendations

  • The American Cancer Society/American Society of Clinical Oncology guidelines recommend acupuncture, physical activity, and physical therapy as the only interventions with demonstrated efficacy for aromatase inhibitor-associated musculoskeletal symptoms 1, 2
  • Only acupuncture and exercise have demonstrated statistically significant improvement in aromatase inhibitor-associated symptoms 1, 2
  • Intensive exercise regimens result in a 20% decrease in aromatase inhibitor-associated pain 1, 2
  • Physical therapy, including stretching and other exercises, has been shown to be effective for managing musculoskeletal symptoms 1, 2

Prevalence and Challenges of Aromatase Inhibitor-Induced Pain

  • Up to 50% of postmenopausal women receiving aromatase inhibitors report arthralgias and myalgias, with 20% experiencing pain severe enough to discontinue treatment 1, 2
  • These symptoms are often not responsive to NSAIDs or acetaminophen 1, 2
  • Poor adherence to aromatase inhibitor therapy increases breast cancer recurrence risk, making symptom management critical 1
  • Assess musculoskeletal symptoms at each clinical encounter 1, 2
  • Offer acupuncture (evidence-based for aromatase inhibitor pain) 1, 2
  • Prescribe intensive exercise regimen (20% pain reduction demonstrated) 1, 2
  • Refer for physical therapy or rehabilitation 1, 2